focus -WSS

focus

author：explore 2025-08-11 16:25:01 - browse：82319

UnitedHealthcare (UHC) health insurance company signage is displayed on an office building in Phoenix, Arizona — PATRICK T. FALLON/AFP via Getty Images

UnitedHealth Group has made it clear that more people, especially older adults, are seeing their doctors and getting more medical care this year. But that is certainly not dragging down the company’s profits.

In the third quarter of this year, UnitedHealth’s net profit increased by more than 11%, to more than $5.8 billion, the company reported Friday.

UnitedHealthcare, the health insurance division of the conglomerate, registered a medical loss ratio of 82.3% in the quarter. That means for every $100 in premiums the company collected, it paid out $82.30 to hospitals, doctors, and other providers — and kept the rest as profit and to cover its own expenses. That ratio was lower than the 82.8% that Wall Street had predicted for the quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Why the world’s most expensive drug might be worth the price

WSS

Hospitals look to new technology to keep health care workers safe

Weight loss drug costs may need more research, senator suggests

Poor hospice wound care hurts patients and families

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Oprah kicked off a national conversation on obesity. Let's have it

Primary care physicians play key roles in Alzheimer's management

explore

focus

explore

Medical records are filled with copy

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Affirmative action in medical school literally saved lives

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Dobbs anniversary: the lost opportunity of abortion as health care

Surge of respiratory disease in China has likely explanation

Walensky prepares to leave CDC — and Congress — behind

Why the world’s most expensive drug might be worth the price

Dobbs anniversary: the lost opportunity of abortion as health care

Ransomware attacks on hospitals: Study outlines patient impact

entertainment

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Scientists boost immune system in aging mice by making it youthful

PBM reforms clear House panel

Wegovy, Zepbound and weight loss drugs that preserve muscle

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

PBM reforms clear House panel

focus

hotspot

Wikipedia

entertainment